Medicare announces new payment rates for COVID-19 monoclonal antibody infusions
Effective immediately, Medicare will pay $750 to administer monoclonal antibodies to COVID-19 patients in their residence or temporary lodging and increase payment to administer them in most other care settings to $450 from $310 to better align payment with provider costs, the Centers for Medicare & Medicaid Services yesterday. CMS is updating its and to reflect the new payment rates.
Related News Articles
Headline
The AHA July 8 wrote in opposition to the 鈥淧atient Access to Higher Quality Health Care Act鈥 (H.R. 4002), which would repeal current law banning the creation鈥
Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare鈥
Headline
The Departments of Justice and Health and Human Services today announced the creation of the DOJ-HHS False Claims Act Working Group to combat health care fraud鈥
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state鈥檚鈥
Headline
The Centers for Medicare & Medicaid Services June 30 issued its calendar year 2026 proposed rule for the home health prospective payment system. This rule鈥
Headline
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state鈥檚 340B contract pharmacy law鈥